AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Director's Dealing Sep 27, 2016

4932_dirs_2016-09-27_88253754-c23b-445b-aa4c-529511bbf266.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8781K

PureTech Health PLC

27 September 2016

PDMR DEALING NOTIFICATION

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael MacLean

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

PureTech Health plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Restricted share unit ("RSU"), each of which entitles the holder to one ordinary share of one pence each in the capital of PureTech Health plc ("Ordinary Share")

GB00BY2Z0H74

b)

Nature of the transaction

Award of RSUs by PureTech Health plc to Michael MacLean pursuant to its Performance Share Plan. The RSUs were granted for nil consideration.

The RSUs will vest in the following manner: 25% to vest on 30 June 2017, and remaining 75% shall vest in equal semi-annual instalments over the three years following 18 January 2017; provided that Michael MacLean continues to be employed by PureTech Health plc on each such vesting date.

Following vesting, Michael MacLean will be required to make a payment of one pence per Ordinary Share on settlement of the RSUs.

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil 150,000

d)

Aggregated information

- Aggregated volume
- Price

N/A

e)

Date of the transaction

26 September 2016

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFQLLLQKFXBBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.